DRGEM Corporation Total Assets
DRGEM Corporation total assets. Based on the latest financial reports, DRGEM Corporation (263690) holds total assets worth ₩131.65 Billion KRW (≈ $89.21 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see DRGEM Corporation (263690) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of DRGEM Corporation (2015–2025)
Total assets of DRGEM Corporation from 2015 to 2025. This chart illustrates how DRGEM Corporation's total assets have evolved over time, based on quarterly financial data. See current stock price of DRGEM Corporation for real-time trading data and today's change.
DRGEM Corporation - Asset Composition Analysis
DRGEM Corporation Total Assets Breakdown (December 2025)
DRGEM Corporation total assets breakdown as of December 2025. DRGEM Corporation's total assets of ₩131.65 Billion consist of 56.2% current assets and 43.8% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 11.2% |
| Accounts Receivable | ₩18.29 Billion | 15.0% |
| Inventory | ₩30.74 Billion | 25.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩4.56 Billion | 3.7% |
| Goodwill | ₩2.98 Billion | 2.4% |
Asset Composition Trend (2015–2025)
This chart illustrates how DRGEM Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore DRGEM Corporation short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DRGEM Corporation's current assets represent 56.2% of total assets in 2025, a decrease from 61.3% in 2015.
- Cash Position: Cash and equivalents constituted 11.2% of total assets in 2025, up from 9.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 25.2% of total assets.
DRGEM Corporation Competitors by Total Assets
Key competitors of DRGEM Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
DRGEM Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.32 | 3.55 | 3.48 |
| Quick Ratio | 1.87 | 1.94 | 2.39 |
| Cash Ratio | 0.00 | 0.00 | 1.41 |
| Working Capital | ₩53.86 Billion | ₩48.67 Billion | ₩41.48 Billion |
DRGEM Corporation - Advanced Valuation Insights
This section examines the relationship between DRGEM Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.56 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | ₩121.97 Billion |
| Market Capitalization | $36.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values DRGEM Corporation's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: DRGEM Corporation's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for DRGEM Corporation (2015–2025)
The table below shows the annual total assets of DRGEM Corporation from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩121.97 Billion ≈ $82.65 Million |
-0.03% |
| 2024-12-31 | ₩122.00 Billion ≈ $82.68 Million |
-4.99% |
| 2023-12-31 | ₩128.41 Billion ≈ $87.02 Million |
+1.35% |
| 2022-12-31 | ₩126.71 Billion ≈ $85.87 Million |
+50.75% |
| 2021-12-31 | ₩84.05 Billion ≈ $56.96 Million |
+15.72% |
| 2020-12-31 | ₩72.63 Billion ≈ $49.22 Million |
+15.20% |
| 2019-12-31 | ₩63.05 Billion ≈ $42.73 Million |
+36.21% |
| 2018-12-31 | ₩46.29 Billion ≈ $31.37 Million |
+34.51% |
| 2017-12-31 | ₩34.41 Billion ≈ $23.32 Million |
+23.68% |
| 2016-12-31 | ₩27.82 Billion ≈ $18.85 Million |
+18.20% |
| 2015-12-31 | ₩23.54 Billion ≈ $15.95 Million |
-- |
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.